// App-Quantinova.ai

BSH19‐OR‐013 : Audit of 24 months of experience using Obinutuzumab and Chlorambucil Treatment for Chronic Lymphocytic Leukaemia at the University Hospital of Wales, Cardiff; Assessing its suitability for use in a nurse led off‐site service

Researchers

Presenter

  • C. Bloodworth

Principal Investigators

  • R. Harries

  • S. Gatto

Medical Centers

  • Dept. of Haematology, University Hospital of Wales, Cardiff, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Obinutuzumab

  • Obinutuzumab Intravenous

  • chlorambucil

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved